DIAMYD: A hot cup of Java! :)A cup and a handle if I ever saw one!
Diamyd has been reporting some great news lately: the Diamyd vaccine showing great results in clinical trials conducted in January this year , as well as getting their manufacturing plant ready for production of the vaccine!
Notice the rising trend in a
−1.60 SEK
−151.85 M SEK
130.00 K SEK
86.36 M
About DIAMYD MEDICAL AB SER. B
Sector
CEO
Ulf Hannelius
Headquarters
Stockholm
Website
Founded
1984
ISIN
SE0005162880
FIGI
BBG004DD90Y1
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DMYD_B is 13.22 SEK — it has decreased by −7.68% in the past 24 hours. Watch DIAMYD MEDICAL AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DIAMYD MEDICAL AB SER. B stocks are traded under the ticker DMYD_B.
DMYD_B stock has risen by 0.46% compared to the previous week, the month change is a −4.62% fall, over the last year DIAMYD MEDICAL AB SER. B has showed a 89.67% increase.
DMYD_B reached its all-time high on Sep 24, 2020 with the price of 72.94 SEK, and its all-time low was 1.46 SEK and was reached on Jun 7, 2013. View more price dynamics on DMYD_B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DMYD_B stock is 8.98% volatile and has beta coefficient of 0.25. Track DIAMYD MEDICAL AB SER. B stock price on the chart and check out the list of the most volatile stocks — is DIAMYD MEDICAL AB SER. B there?
Today DIAMYD MEDICAL AB SER. B has the market capitalization of 1.37 B, it has increased by 2.77% over the last week.
Yes, you can track DIAMYD MEDICAL AB SER. B financials in yearly and quarterly reports right on TradingView.
DMYD_B net income for the last quarter is −49.74 M SEK, while the quarter before that showed −40.08 M SEK of net income which accounts for −24.12% change. Track more DIAMYD MEDICAL AB SER. B financial stats to get the full picture.
No, DMYD_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMYD MEDICAL AB SER. B EBITDA is −144.85 M SEK, and current EBITDA margin is −111.42 K%. See more stats in DIAMYD MEDICAL AB SER. B financial statements.
Like other stocks, DMYD_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMYD MEDICAL AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIAMYD MEDICAL AB SER. B technincal analysis shows the strong sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIAMYD MEDICAL AB SER. B stock shows the sell signal. See more of DIAMYD MEDICAL AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.